Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer

Published:2021-09 Issue: Volume:Volume 13 Page:7497-7503
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Tani Tetsuo^ORCID,Nakachi Ichiro^ORCID,Ikemura Shinnosuke,Nukaga Shigenari,Ohgino Keiko,Kuroda Aoi,Terai Hideki,Masuzawa Keita,Shinozaki Taro,Ishioka Kota,Funatsu Yohei,Koh Hidefumi,Fukunaga Koichi^ORCID,Soejima Kenzo

Publisher

Informa UK Limited

Subject

Oncology

Reference17 articles.

1. Cancer statistics, 2019

2. Metastatic sites and survival in lung cancer

3. Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers

4. Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma

5. Malignant Pleural Effusions

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flourine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging of Peritoneal Carcinomatosis in Lung Cancer: A Case Study;World Journal of Nuclear Medicine;2024-06-27

2. Therapeutic Strategies and Oncological Outcome of Peritoneal Metastases from Lung Cancer: A Systematic Review and Pooled Analysis;Current Oncology;2023-03-01

3. Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation;OncoTargets and Therapy;2022-11

4. Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature;Applied Sciences;2022-07-27

5. Case Report: Afatinib Sensitivity in Rare EGFR E746_L747delinsIP Mutated LUAD With Peritoneal Metastases;Frontiers in Oncology;2022-05-31